Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)-famotidine complex.
The mechanochemical synthesis and characterization of a zinc complex with famotidine is described. The complex was characterized by microanalysis and a number of spectroscopic techniques. The complex was of M:L dihydrate type. Derivatization of famotidine with zinc appears to enhance the activity of the drug by inhibiting the growth of Helicobacter pylori (two reference and 34 clinical isolates). The complex inhibited the growth of H. pylori in an MIC range of 1-8 microg mL(-1). The anti-H. pylori activity of the zinc-famotidine complex against antibiotic-resistant strains was nearly comparable to that of antibiotic-susceptible strains. The complex was found to be far less toxic than the parent drug, as demonstrated by its higher LD(50) value. In the human urease enzyme inhibition assay the complex exhibited significant inhibition. The new complex appears to be more useful in eradicating both the antibiotic-susceptible and antibiotic-resistant strains of H. pylori.
Department of Chemistry, University of Sargodha, Sargodha, Pakistan.
Muhammad
M
Amin
Mohammad S
MS
Iqbal
Roy W
RW
Hughes
Safyan A
SA
Khan
Paul A
PA
Reynolds
Virve I
VI
Enne
Sajjad-ur-Rahman
Akmal S
AS
Mirza
D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D000897:Anti-Ulcer Agents; D004352:Drug Resistance, Microbial; D015738:Famotidine / Q000737:chemistry* / Q000494:pharmacology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D014510:Urease / Q000037:antagonists & inhibitors*; D015032:Zinc / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D015738:Famotidine; D014510:Urease; D015032:Zinc